Satya Das

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Manisha H. Shah, Whitney Goldner, Al B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2021 · 602 citations

Medicine, Nuclear Medicine, Oncology +17

Expression of PD-1 and PD-L1 in poorly differentiated neuroendocrine carcinomas of the digestive system: a potential target for anti–PD-1/PD-L1 therapy

Jordan Roberts, Raul S. González, Satya Das et al. · Human Pathology · 2017 · 52 citations · Full text

Medicine, Oncology, Pathology +13

Improving the phenotype risk score as a scalable approach to identifying patients with Mendelian disease

Lisa Bastarache, Jacob Hughey, Julie A Bastraache et al. · Journal of the American Medical Informatics Association · 2019 · 51 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer

İbrahim Halil Şahin, Subir Goyal, Yoanna S Pumpalova et al. · The Oncologist · 2021 · 47 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy

Satya Das, Kristen K. Ciombor, Sigurdís Haraldsdóttir et al. · The Oncologist · 2020 · 42 citations · Full text

Medicine, Immunology, Oncology +17